Oncology
Showing of 56 results
Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy
University Hospitals Seidman Cancer Center researcher on team who made the first of its kind discovery published in Oncotarget.
Northeast Ohio Children’s Hospitals and Dunkin’ Joy in Childhood Foundation Host Prom for Teen Cancer Patients and Survivors
On Friday, June 13, more than 48 local teens battling cancer or in recovery, along with their special guests, will celebrate an unforgettable night at the “Let’s Glow” prom event.
University Hospitals Seidman Cancer Center to Host Northeast Ohio’s Premier Culinary Event ─ Five Star Sensation ─ June 28
Vinnie Cimino, Chef/Partner of Cordelia, returns to lead this year’s lineup of internationally renowned chefs and vintners.
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.
University Hospitals to Invest $39 Million to Build Regional Cancer Hub at UH TriPoint Medical Center
Regional hub will help better serve patients east of Cleveland; Oncology services will also be expanded at UH Minoff Health Center in Beachwood.
University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients
The radiation treatment allows for unprecedented targeting of tumors while sparing healthy organs in almost a dozen different types of cancer.
UH Seidman Cancer Center Offers Patients Rare Access to New Kidney Cancer Tracer
UH Seidman Cancer Center is one of just a few cancer centers nationwide to offer its patients early access to a novel and more sensitive method of diagnosing kidney cancer.